Related Experiment Video
Updated: Jul 8, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
Thalidomide-induced reversible interstitial pneumonitis in a patient with recurrent ovarian cancer
Barbara M Buttin1, Michael J Moore
1Department of Obstetrics and Gynecology, Section of Gynecologic Oncology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Background:
Thalidomide is an oral immunomodulatory agent with antiangiogenic properties and activity in ovarian cancer. Pulmonary toxicity unrelated to venous thromboembolism is rare and its etiology is poorly understood.
Case:
We present the first reported case of reversible drug-induced interstitial lung disease in a patient with recurrent ovarian cancer treated with weekly topotecan and thalidomide. The patient's symptoms and radiographic findings completely resolved upon discontinuing thalidomide while continuing on topotecan.
Conclusion:
Due to its antiangiogenic properties and good tolerance, thalidomide is an attractive agent for the treatment of recurrent ovarian cancer. Gynecologic oncologists and pulmonologists should be aware that acute interstitial lung disease is a possible side effect that appears easily reversible when the drug is stopped.
Related Concept Videos
Teratogenicity
Pneumothorax-II
Clinical Manifestations:
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Oogenesis
Chemotherapy-Induced Nausea and Vomiting: 5-HT3 Receptor Antagonists